Design and development of molecular imaging probes.
Molecular imaging, the visualization, characterization and measurement of biological processes at the cellular, subcellular level, or even molecular level in living subjects, has rapidly gained importance in the dawning era of personalized medicine. Molecular imaging takes advantage of the traditional diagnostic imaging techniques and introduces molecular imaging probes to determine the expression of indicative molecular markers at different stages of diseases and disorders. As a key component of molecular imaging, molecular imaging probe must be able to specifically reach the target of interest in vivo while retaining long enough to be detected. A desirable molecular imaging probe with clinical translation potential is expected to have unique characteristics. Therefore, design and development of molecular imaging probe is frequently a challenging endeavor for medicinal chemists. This review summarizes the general principles of molecular imaging probe design and some fundamental strategies of molecular imaging probe development with a number of illustrative examples.
Chen
Kai
K
Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, MD 20892, USA. chenkai@usc.edu
Chen
Xiaoyuan
X
D006801:Humans; D057054:Molecular Imaging / Q000379:methods*; D015335:Molecular Probes / Q000138:chemical synthesis* / Q000737:chemistry
D015335:Molecular Probes
J Nucl Med. 2010 Feb;51(2):251-258
20124048
Radiology. 2005 Sep;236(3):753-5
16118158
Methods Mol Biol. 2009;574:47-62
19685299
Cancer Res. 2009 Feb 1;69(3):873-8
19155297
Curr Pharm Des. 2008;14(28):2943-73
18991712
Expert Opin Ther Targets. 2008 Apr;12(4):383-9
18348676
J Nucl Med. 2003 Sep;44(9):1413-20
12960185
Mini Rev Med Chem. 2006 Feb;6(2):227-34
16472190
Angew Chem Int Ed Engl. 2001 Jun 1;40(11):2004-2021
11433435
Genes Dev. 2003 Mar 1;17(5):545-80
12629038
Nat Rev Cancer. 2002 Sep;2(9):683-93
12209157
Small. 2007 Nov;3(11):1840-54
17943716
Cancer Res. 2004 Nov 1;64(21):8009-14
15520209
Bioconjug Chem. 2009 Dec;20(12):2199-213
19719118
Bioconjug Chem. 2007 May-Jun;18(3):765-72
17348700
Eur J Nucl Med. 1999 Apr;26(4):328-32
10199937
J Med Chem. 2008 Aug 14;51(15):4504-17
18637669
Clin Cancer Res. 2008 Feb 1;14(3):731-41
18245533
J Clin Oncol. 2008 May 1;26(13):2124-30
18445841
Chem Commun (Camb). 2008 Sep 28;(36):4250-60
18802536
Cancer Res. 2004 Feb 15;64(4):1411-8
14973076
Nat Rev Cancer. 2002 Jan;2(1):11-8
11902581
J Nucl Med. 2007 Feb;48(2):295-303
17268028
Thromb Res. 2002 Sep 15;107(6):365-71
12565725
Mol Imaging Biol. 2002 Oct;4(5):352-4
14537109
Curr Top Med Chem. 2001 Sep;1(4):277-351
11899112
Bioconjug Chem. 2007 Nov-Dec;18(6):1987-94
18030991
Ann Oncol. 2002;13 Suppl 4:115-24
12401677
Ann N Y Acad Sci. 2004 May;1020:32-40
15208181
Curr Opin Biotechnol. 2005 Feb;16(1):63-72
15722017
Mol Cancer Ther. 2006 Nov;5(11):2624-33
17121909
Protein Sci. 2006 Jan;15(1):14-27
16373474
J Med Chem. 2008 Oct 9;51(19):5901-4
18785727
J Biol Chem. 1954 Oct;210(2):581-95
13211595
Drug Discov Today. 2003 Dec 15;8(24):1128-37
14678739
Neoplasia. 2007 Feb;9(2):166-80
17356713
Cancer Biother Radiopharm. 2009 Jun;24(3):289-302
19538051
Acc Chem Res. 2009 Jul 21;42(7):832-41
19530674
J Nucl Med. 2008 May;49(5):796-803
18413389
J Natl Cancer Inst. 1960 Feb;24:267-81
14414406
Eur J Endocrinol. 1999 Jul;141(1):1-14
10407215
Bioconjug Chem. 2006 May-Jun;17(3):662-9
16704203
Clin Chem. 2006 Nov;52(11):2162-4
18061989
Bioconjug Chem. 2005 Nov-Dec;16(6):1433-41
16287239
Clin Cancer Res. 2007 Oct 15;13(20):6070-9
17947470
Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17904-9
19815497
Cancer Res. 2000 Oct 15;60(20):5649-58
11059756
Eur J Nucl Med Mol Imaging. 2009 Aug;36(8):1283-95
19288096
Nature. 1991 Nov 7;354(6348):82-4
1944576
J Nucl Med. 2003 Mar;44(3):341-6
12620998
Eur J Nucl Med Mol Imaging. 2009 Jan;36(1):37-47
18690434
Bioconjug Chem. 2009 Dec;20(12):2342-7
19908826
Chem Rev. 1997 Apr 1;97(2):411-448
11848877
Eur J Cancer. 2004 Nov;40(17):2623-32
15541963
Radiology. 2001 May;219(2):316-33
11323453
Science. 1996 Jul 26;273(5274):458-64
8662529
J Nucl Med. 2000 Aug;41(8):1369-79
10945530
J Nucl Med. 2007 Nov;48(11):1862-70
17942800
Int J Appl Radiat Isot. 1982 May;33(5):363-9
7095877
Nucl Med Biol. 2009 May;36(4):389-93
19423006
Chem Biol. 2000 Jan;7(1):17-25
10662687
J Nucl Med. 2008 Mar;49(3):453-61
18287274
J Nucl Med. 2006 Dec;47(12):1968-76
17138739
J Am Chem Soc. 2004 Jun 30;126(25):7740-1
15212497
J Biosci Bioeng. 2005 May;99(5):448-56
16233816
Bioconjug Chem. 2001 Jan-Feb;12(1):7-34
11170362
Cancer Res. 2001 Mar 1;61(5):1781-5
11280722
Cancer Res. 2009 Mar 15;69(6):2435-42
19276378
J Proteome Res. 2005 Jul-Aug;4(4):1104-9
16083259
J Nucl Med. 2003 Dec;44(12):1927-32
14660718
J Nucl Med. 1995 Oct;36(10):1806-10
7562047
J Nucl Med. 2008 May;49(5):804-13
18413392
Q J Nucl Med Mol Imaging. 2007 Jun;51(2):152-63
17420716
Chembiochem. 2009 May 25;10(8):1293-6
19422008
Nature. 2000 Mar 30;404(6777):465-70
10761907
J Med Chem. 2006 Jul 27;49(15):4767-76
16854083
J Nucl Med. 2001 Dec;42(12):1847-55
11752084
Bioconjug Chem. 2010 Feb 17;21(2):270-8
20102181
Cancer Biomark. 2008;4(6):287-305
19126958
Nat Biotechnol. 2001 Jul;19(7):631-5
11433273
Bull Environ Contam Toxicol. 2005 May;74(5):899-903
16097324
Eur J Nucl Med Mol Imaging. 2009 Jan;36(1):94-103
18712382
Nat Biotechnol. 2006 Aug;24(8):905-8
16900126
Drug Discov Today. 2009 Feb;14(3-4):147-54
19135549
J Nucl Med. 2002 Dec;43(12):1699-706
12468522
FASEB J. 2006 Aug;20(10):1599-610
16873883
Acta Neurol Scand. 1992 Feb;85(2):95-102
1574995
Anal Chem. 2004 Sep 15;76(18):5302-12
15362886
Mol Imaging Biol. 2010 Jun;12(3):316-24
19779897
J Am Chem Soc. 2003 Jul 2;125(26):7766-7
12822971
J Med Chem. 2008 Jul 10;51(13):4030-7
18543899
J Nucl Med. 2007 Jun;48(6):987-94
17504880
Nat Chem Biol. 2006 Jul;2(7):381-9
16767086
Science. 2006 May 26;312(5777):1168-71
16728630